Journal of Neurology

, Volume 262, Issue 5, pp 1238–1246 | Cite as

Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold?

  • Antonio Palasí
  • Belén Gutiérrez-Iglesias
  • Montse Alegret
  • Francesc Pujadas
  • Mikel Olabarrieta
  • Diana Liébana
  • Manolo Quintana
  • José Álvarez-Sabín
  • Mercè Boada
Original Communication

Abstract

Early-onset and late-onset Alzheimer’s disease (EOAD and LOAD) are two forms of the disease with the same characteristic neuropathological hallmarks. However, higher burdens of neuritic plaques and neurofibrillary tangles in frontal and parietal lobes have been found in EOAD than in LOAD patients. Thus, the EOAD subjects may have a differentiated clinical presentation compared to the LOAD ones. Some authors have found less hippocampal memory presentations and more focal cortical abnormalities (such as visuoconstructive or executive dysfunction) in EOAD than LOAD patients. The aim of the present study was to determine which initial clinical profiles differ between EOAD and LOAD; and to analyze whether another age cut-off could discriminate better between EOAD and LOAD clinical presentations than the conventional limit of 65. All patients fulfilling NINCDS-ADRDA criteria for probable Alzheimer’s disease who referred to our Hospital between October 2007 and December 2012 were included in the study. The conventional age limit of 65 was established to distinguish between EOAD and LOAD. Baseline neuropsychological scores, adjusted for age and education, were compared between both groups. A total of 181 patients (38 EOAD, 143 LOAD) entered in the analysis. Sex distribution and time of evolution of symptoms did not differ between groups. The EOAD patients performed worse than LOAD in attentional, imitation praxis and verbal learning tests. In addition, the age cut-off of 70 was found to differentiate between early- and late-onset groups better than the standard cut-off of 65 years old. Our results support a differentiated neuropsychological impairment pattern in EOAD compared to LOAD.

Keywords

Alzheimer’s disease Early-onset Late-onset Clinical presentation Neuropsychology 

Notes

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standard

The study was approved by the local ethics committee and was therefore performed in accordance with ethical standards according to WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects.

References

  1. 1.
    Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797–811CrossRefPubMedGoogle Scholar
  2. 2.
    Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL (2007) Early-onset Alzheimer’s disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol 20:29–33CrossRefPubMedGoogle Scholar
  3. 3.
    Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL (2002) Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 28:218–227CrossRefPubMedGoogle Scholar
  4. 4.
    Erten-Lyons D, Dodge HH, Woltjer R, Silbert LC, Howieson DB, Kramer P, Kaye JA (2013) Neuropathological basis of age-associated brain atrophy. JAMA Neurol 70:616–622PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Mendez MF, Lee AS, Joshi A, Shapira JS (2012) Nonamnestic presentations of early-onset Alzheimer’s disease. J Alzheimers Dis 27:413–420CrossRefGoogle Scholar
  6. 6.
    Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC (1996) Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer’s disease: a CERAD analysis, part XII. Neurology 46:136–141CrossRefPubMedGoogle Scholar
  7. 7.
    Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y (1994) Age at onset of Alzheimer’s disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44:1215–1220CrossRefPubMedGoogle Scholar
  8. 8.
    Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM (2013) Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease. Neurobiol Aging 34:2014–2022CrossRefPubMedGoogle Scholar
  9. 9.
    Gour N, Felician O, Didic M, Koric L, Gueriot C, Chanoine V, Confort-Gouny S, Guye M, Ceccaldi M, Ranjeva JP (2014) Functional connectivity changes differ in early and late-onset Alzheimer’s disease. Hum Brain Mapp 35:2978–2994. doi: 10.1002/hbm.22379 CrossRefPubMedGoogle Scholar
  10. 10.
    Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain 130:720–730CrossRefPubMedGoogle Scholar
  11. 11.
    Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E (2005) Voxel-based morphometric comparison between early- and late-onset mild Alzheimer’s disease and assessment of diagnostic performance of Z score images. AJNR Am J Neuroradiol 26:333–340PubMedGoogle Scholar
  12. 12.
    Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF (2012) Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 27:520–529PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Mendez MF (2012) Early-onset Alzheimer’s disease: nonamnestic subtypes and type 2 AD. Arch Med Res 43:677–685PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, Kim SE, Lee KH, Na DL (2005) Glucose metabolism in early onset versus late onset Alzheimer’s disease: an SPM analysis of 120 patients. Brain 128:1790–1801CrossRefPubMedGoogle Scholar
  15. 15.
    Van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P (2011) Early-onset versus late-onset Alzheimer’s disease: the case of the missing APOE ε4 allele. Lancet Neurol 10:280–288CrossRefPubMedGoogle Scholar
  16. 16.
    Seltzer B, Sherwin I (1983) A comparison of clinical features in early and late onset primary degenerative dementia: one entity or two? Arch Neurol 40:143–146CrossRefPubMedGoogle Scholar
  17. 17.
    Filley CM, Kelly J, Heaton RK (1986) Neuropsychologic features of early- and late-onset Alzheimer’s disease. Arch Neurol 43:574–576CrossRefPubMedGoogle Scholar
  18. 18.
    Smits LL, Pijnenburg YAL, Koedam E, van der Vlies AE, Reuling IEW, Koene T, Teunissen CE, Scheltens P, van der Flier WM (2012) Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 30:101–108PubMedGoogle Scholar
  19. 19.
    Sá F, Pinto P, Cunha C, Lemos R, Letra L, Simoes M, Santana I (2012) Differences between early and late-onset Alzheimer’s disease in neuropsychological tests. Front Neurol 3:81PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Koedam E, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YAL (2010) Early-versus late-onset Alzheimer’s disease: more than age alone. J Alzheimers Dis 19:1401–1408PubMedGoogle Scholar
  21. 21.
    Licht EA, McMurtray AM, Saul RE, Mendez MF (2007) Cognitive differences between early- and late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 22:218–222CrossRefPubMedGoogle Scholar
  22. 22.
    Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI (1987) Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia 25:807–816CrossRefPubMedGoogle Scholar
  23. 23.
    Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atyical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498CrossRefPubMedGoogle Scholar
  24. 24.
    Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, Hodges JR (1996) Progressive biparietal atrophy: an atypical presentation of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 61:388–395PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Albert M, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Dubois B, Feldman HH, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Megura K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMedGoogle Scholar
  29. 29.
    Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD (2010) The diagnosis of young-onset dementia. Lancet Neurol 9:793–806PubMedCentralCrossRefPubMedGoogle Scholar
  30. 30.
    Spalletta G, De Luca V, Padovani A, Rozzini L, Perri R, Bruni A, Canonico V, Trequattrini A, Bellelli G, Pettenati C, Pazzelli F, Caltagirone C, Orfei MD (2013) Early onset versus late onset in Alzheimer’s disease: what is the reliable cut-off? Adv Alzheimer Dis 2:40–47CrossRefGoogle Scholar
  31. 31.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944CrossRefPubMedGoogle Scholar
  32. 32.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading cognitive states of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMedGoogle Scholar
  33. 33.
    Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, Folstein M, Stern Y (1995) A standardized technique for establishing onset and duration of symptoms of Alzheimer’s disease. Arch Neurol 52:961–966CrossRefPubMedGoogle Scholar
  34. 34.
    Reitan RM, Davison LA (1974) Clinical neuropsychology: current status and applications. Hemisphere, New YorkGoogle Scholar
  35. 35.
    Wechsler D (1997) WAIS–III. Wechsler Adult Intelligence Scale. Technical manual, 3rd edn. The Psychological Corporation, San AntonioGoogle Scholar
  36. 36.
    Wechsler D (1997) WMS–III. Wechsler Memory Scale. Administration and scoring manual, 3rd edn. The Psychological Corporation, San AntonioGoogle Scholar
  37. 37.
    Kaplan EF, Goodglass H, Weintraub S (1983) The Boston Naming Test, 2nd edn. Lea & Febiger, PhiladelphiaGoogle Scholar
  38. 38.
    Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders, 2nd edn. Lea & Febiger, PhiladelphiaGoogle Scholar
  39. 39.
    Peña-Casanova J (1991) Programa Integrado de Exploración Neuropsicológica. Test Barcelona (Integrated Program of Neuropsychological Assessment. Barcelona Test). Masson, Barcelona, SpainGoogle Scholar
  40. 40.
    Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New YorkGoogle Scholar
  41. 41.
    Benton AL, Varney NR, Hamsher KS (1978) Visuospatial judgment: a clinical test. Arch Neurol 35:364–367CrossRefPubMedGoogle Scholar
  42. 42.
    Golden CJ (1980) In reply to Adams “In search of Luria’s battery: a false start”. J Consult Clin Psychol 48:517–521CrossRefPubMedGoogle Scholar
  43. 43.
    Della Sala S, Laiacona M, Trivelli C, Spinnler H (1995) Poppelreuter-Ghent overlapping figures test. Its sensitivity to age, and its clinical use. Arch Clin Neuropsychol 10:511–534CrossRefPubMedGoogle Scholar
  44. 44.
    Loring DW (1985) Neuropsychological patterns of presenile and senile dementia of the Alzheimer type. Neuropsychologia 23:351–357CrossRefPubMedGoogle Scholar
  45. 45.
    Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR (1996) Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol 53:1056–1061CrossRefPubMedGoogle Scholar
  46. 46.
    Balasa M, Gelpi E, Antonell A, Rey MJ, Sanchez-Valle R, Molinuevo JL, Lladó A, Neurological Tissue Bank/University of Barcelona/Hospital Clínic NTB/UB/HC Collaborative Group (2011) Clinical features and APOE genotype of patollogically proven early-onset Alzheimer disease. Neurology 76:1720–1725CrossRefPubMedGoogle Scholar
  47. 47.
    Toyota Y, Ikeda M, Shinagawa S, Matsumoto N, Hokoishi K, Fukuhara R, Ishikawa T, Mori T, Adachi H, Komori K, Tanabe H (2007) Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. Int J Geriatr Psychiatry 22:896–901CrossRefPubMedGoogle Scholar
  48. 48.
    Krishna R, Moustafa AA, Eby LA, Skeen LC, Myers CE (2012) Learning and generalization in healthy aging: implication for frontostriatal and hippocampal function. Cogn Behav Neurol 25:7–15PubMedCentralCrossRefPubMedGoogle Scholar
  49. 49.
    Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA (2014) Patterns of cognitive function in aging: the Rotterdam study. Eur J Epidemiol 29:133–140CrossRefPubMedGoogle Scholar
  50. 50.
    Salthouse TA (2000) Aging and measures of processing speed. Biol Psychol 54:35–54CrossRefPubMedGoogle Scholar
  51. 51.
    Fujimori M, Imamura T, Yamashita H, Hirono N, Ikejiri Y, Shimomura T, Mori E (1998) Age at onset and visuocognitive disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord 12:163–166CrossRefPubMedGoogle Scholar
  52. 52.
    Rogers BS, Lippa CF (2012) A clinical approach to early-onset inheritable dementia. Am J Alzheimers Dis Other Demen 27:154–161CrossRefPubMedGoogle Scholar
  53. 53.
    Renvoize E, Hanson M, Dale M (2011) Prevalence and causes of young onset dementia in an English health district. Int J Geriatr Psychiatry 26:106–107CrossRefPubMedGoogle Scholar
  54. 54.
    Mendez MF (2006) The accurate diagnosis of early-onset dementia. Int J Psychiatry Med 36:401–412CrossRefPubMedGoogle Scholar
  55. 55.
    Forstl H, Burns A, Levy R, Cairns N (1994) Neuropathological correlates of psychotic phenomena in confirmed Alzheimer’s disease. Br J Psychiatry 165:53–59CrossRefPubMedGoogle Scholar
  56. 56.
    McMurtray AM, Ringman J, Chao SZ, Licht E, Saul RE, Mendez MF (2006) Family history of dementia in early-onset versus very late-onset Alzheimer’s disease. Int J Geriatr Psychiatry 21:597–598CrossRefPubMedGoogle Scholar
  57. 57.
    Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Backman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L (2006) Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 396:23–27CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Antonio Palasí
    • 1
  • Belén Gutiérrez-Iglesias
    • 1
  • Montse Alegret
    • 2
  • Francesc Pujadas
    • 1
  • Mikel Olabarrieta
    • 1
  • Diana Liébana
    • 1
  • Manolo Quintana
    • 1
  • José Álvarez-Sabín
    • 1
  • Mercè Boada
    • 1
    • 2
  1. 1.Unitat de Demències, Department of NeurologyVall d’Hebron Research Institute, Vall d’Hebron University Hospital, Universitat Autònoma de BarcelonaBarcelonaSpain
  2. 2.Memory Clinic of Fundació ACE, Institut Català de Neurociències AplicadesBarcelonaSpain

Personalised recommendations